skip to Main Content

DEA: Hemp CBD is a Schedule I Drug

Last week, the Drug Enforcement Agency (DEA) ruled that cannabidiol (CBD) falls within the Schedule I drug classification of the Controlled Substances Act (CSA) and has received an official drug code. Companies have 30-days to update their licenses and cease…

Read More

FDA Releases Unique Device Identifier Draft Guidance

Zachary Brennan of the Regulatory Affairs Professional Society (RAPS) outlined the guidance from the Food and Drug Administration (FDA) about the expected content and forms for the Unique Device Identifier (UDI) for medical device manufacturers and distributors that are coming…

Read More

Election 2016: The Future of Pharma Under Clinton

Note: This is not an endorsement of Hillary Clinton. InstantGMP™ will be reporting on various aspects of the Presidential candidates’ platforms and their potential impact. By Kelly L. Waters, Marketing Manager (Ms. Waters does not endorse Clinton, she’s just the…

Read More

Election 2016: The Future of Pharma Under Trump

Note: This is not an endorsement of Donald Trump. InstantGMP™ will be reporting on various aspects of the Presidential candidates’ platforms and their potential impact. By Kelly L. Waters, Marketing Manager (Ms. Waters does not endorse Trump, she’s just the…

Read More
Back To Top